Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

GSKGSK
10 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in GLAXOSMITHKLINE PLC-SPON ADR

Point72 Asset Management, L.P. holds 2.7M shares of GSK (GLAXOSMITHKLINE PLC-SPON ADR), worth $139.1M as of 2026-Q2. This is a new position. GSK represents 0.2% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$139.1M

Current Shares

2.7M

Total Value Change

+$3M

Total Shares Change

-2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2.7M
-
$139.1M0.2%$52.42
50
2026-Q1
Exited
0
-100.0%
$00.0%$57.07
0
2025-Q4
New
1.5M
-
$72.3M0.1%$49.30
41
2024-Q2
Exited
0
-100.0%
$00.0%$35.22
0
2024-Q1
Increased
543,100
+2089.9%
$23.3M0.1%$38.90
46
2023-Q4
New
24,800
-
$919,0880.0%$33.30
35
2023-Q2
Exited
0
-100.0%
$00.0%$31.38
0
2023-Q1
Decreased
106,100
-98.4%
$3.8M0.0%$31.03
0
2022-Q4
Increased
6.5M
+40.0%
$227.4M0.8%$30.35
57
2022-Q3
New
4.6M
-
$136M0.5%$25.18
59

Other major holders of GSK: FMR LLC, DODGE & COX

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used